Literature DB >> 33434384

Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review.

Sara Manti1, Giuseppe Fabio Parisi1, Maria Papale1, Gian Luigi Marseglia2, Amelia Licari2, Salvatore Leonardi1.   

Abstract

Entities:  

Year:  2021        PMID: 33434384     DOI: 10.1002/iid3.384

Source DB:  PubMed          Journal:  Immun Inflamm Dis        ISSN: 2050-4527


× No keyword cloud information.
  3 in total

Review 1.  An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Authors:  Roberto Bernardini; Gaia Toschi Vespasiani; Arianna Giannetti
Journal:  Medicina (Kaunas)       Date:  2022-04-29       Impact factor: 2.948

Review 2.  Pediatric usage of Omalizumab: A promising one.

Authors:  Lin Yu; Huishan Zhang; Jianwei Pan; Leping Ye
Journal:  World Allergy Organ J       Date:  2021-12-11       Impact factor: 4.084

Review 3.  Vernal keratoconjunctivitis: state of art and update on treatment.

Authors:  Giulia Brindisi; Bianca Cinicola; Caterina Anania; Giovanna De Castro; Marcella Nebbioso; Michele Miraglia Del Giudice; Amelia Licari; Carlo Caffarelli; Maria De Filippo; Fabio Cardinale; Marzia Duse; Anna Maria Zicari
Journal:  Acta Biomed       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.